Covered recipient · General Payments record
PHILLIP H OMOHUNDRO
Allopathic & Osteopathic Physicians Orthopaedic Surgery
General Payments · PY2018–2024
$8,892.43
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $982.99 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Anika Therapeutics, Inc. | $286.50 | 3 |
| Episurf Medical, Inc. | $200.17 | 1 |
| Abbott Laboratories | $152.43 | 1 |
| ABBVIE INC. | $149.03 | 3 |
| Zimmer Biomet Holdings, Inc. | $65.23 | 2 |
| Smith & Nephew, Inc. | $40.04 | 1 |
| Dynasplint Systems Inc. | $24.68 | 1 |
| Amgen Inc. | $22.74 | 1 |
| ACUMED LLC | $21.73 | 1 |
| DePuy Synthes Sales Inc. | $20.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $152.43 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125314146 | CMS |
| ABBVIE INC. | $122.67 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105154545 | CMS |
| ABBVIE INC. | $20.80 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105154547 | CMS |
| ABBVIE INC. | $5.56 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105154549 | CMS |
| ACUMED LLC | $21.73 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125025649 | CMS |
| Amgen Inc. | $22.74 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115981468 | CMS |
| Anika Therapeutics, Inc. | $150.47 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136024802 | CMS |
| Anika Therapeutics, Inc. | $82.42 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136024818 | CMS |
| Anika Therapeutics, Inc. | $53.61 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136024834 | CMS |
| DePuy Synthes Sales Inc. | $20.44 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077854320 | CMS |
| Dynasplint Systems Inc. | $24.68 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1063616087 | CMS |
| Episurf Medical, Inc. | $200.17 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081974989 | CMS |
| Smith+Nephew, Inc. | $40.04 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149522835 | CMS |
| Zimmer Biomet Holdings, Inc. | $50.12 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1155042247 | CMS |
| Zimmer Biomet Holdings, Inc. | $15.11 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1155042257 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.